AbbVie
ABBV
$19,441
Share price
-0.31%
Change (1 day)
32.44%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
Market capitalization of AbbVie (ABBV)
Market cap: $34.359 Trillion
As of January 2026 AbbVie has a market cap of $34.359 Trillion. This makes AbbVie the world's 28th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of AbbVie from 2012 to 2026
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2026 | $34.359 T | -5.83% |
| 2025 | $36.487 T | 35.21% |
| 2024 | $26.985 T | 18.48% |
| 2023 | $22.777 T | -3.69% |
| 2022 | $23.650 T | 32.74% |
| 2021 | $17.816 T | 28.78% |
| 2020 | $13.834 T | 48.16% |
| 2019 | $9.337 T | -2.05% |
| 2018 | $9.532 T | -3.3% |
| 2017 | $9.857 T | 42.55% |
| 2016 | $6.915 T | 9.11% |
| 2015 | $6.337 T | -3.98% |
| 2014 | $6.600 T | 27.44% |
| 2013 | $5.178 T | 75.25% |
| 2012 | $2.955 T |
End of Day market cap according to different sources
On Jan 18th, 2026 the market cap of AbbVie was reported to be:
$34.359 Trillion
$34.359 Trillion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer
PFE
|
$13.227 T | -61.50% | ๐บ๐ธ USA |
 Bristol-Myers Squibb
BMY
|
$10.203 T | -70.31% | ๐บ๐ธ USA |
 Eli Lilly
LLY
|
$84.428 T | 145.72% | ๐บ๐ธ USA |
 Amgen
AMGN
|
$16.136 T | -53.04% | ๐บ๐ธ USA |
 Gilead Sciences
GILD
|
$14.057 T | -59.09% | ๐บ๐ธ USA |
 Biogen
BIIB
|
$2.187 T | -93.63% | ๐บ๐ธ USA |
 GlaxoSmithKline
GSK
|
$8.838 T | -74.28% | ๐ฌ๐ง UK |
 AstraZeneca
AZN
|
$26.554 T | -22.72% | ๐ฌ๐ง UK |
 Neurocrine Biosciences
NBIX
|
$1.197 T | -96.52% | ๐บ๐ธ USA |